<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T03:12:33Z</responseDate>
  <request identifier="oai:figshare.com:article/33961912" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33961912</identifier>
        <datestamp>2026-09-22T05:30:12Z</datestamp>
        <setSpec>category_658</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Supplementary file 2_Exercise-responsive endocrine-metabolic mediators in diabetes and cardiometabolic disorders: a systematic scoping review and evidence map.xlsx</dc:title>
          <dc:creator>Zihang Zhao (20505904)</dc:creator>
          <dc:creator>Yousheng Zhang (1626661)</dc:creator>
          <dc:creator>Zihan Liu (5174729)</dc:creator>
          <dc:creator>Qianye Li (25087624)</dc:creator>
          <dc:creator>Teng Pan (6550055)</dc:creator>
          <dc:creator>Shuo Yang (209399)</dc:creator>
          <dc:creator>Xin Wang (91924)</dc:creator>
          <dc:creator>Lianxin Song (22850530)</dc:creator>
          <dc:creator>Zhuoyi Li (7348397)</dc:creator>
          <dc:creator>Ruipeng Zhang (4603846)</dc:creator>
          <dc:creator>Zhiyong Hou (456547)</dc:creator>
          <dc:subject>Cell Metabolism</dc:subject>
          <dc:subject>adipokines</dc:subject>
          <dc:subject>cardiometabolic disorders</dc:subject>
          <dc:subject>diabetes</dc:subject>
          <dc:subject>evidence map</dc:subject>
          <dc:subject>exercise</dc:subject>
          <dc:subject>exerkines</dc:subject>
          <dc:subject>extracellular vesicles</dc:subject>
          <dc:subject>myokines</dc:subject>
          <dc:description>Background&lt;p&gt;Exercise-responsive endocrine-metabolic mediators may contribute to the systemic cardiometabolic adaptations induced by physical activity, but the literature spans diverse mediator classes, exercise paradigms, disease contexts, and experimental models. We conducted a systematic scoping review and evidence map to characterize the structure of this evidence and the biological relations examined across the field.&lt;/p&gt;Methods&lt;p&gt;PubMed/MEDLINE, Web of Science Core Collection, and Scopus were searched from database inception through 7 August 2026. Titles and abstracts, followed by full texts, were independently assessed by two reviewers, with third-reviewer adjudication where required. Eligible primary reports underwent a separate round of independent full-text data charting using a relational framework linking reports, exercise contrasts, and mediator evidence. Cardiometabolic contexts and outcome domains were coded using multi-label rules, synonymous mediator terminology was harmonized, and companion publications were linked before study-level synthesis. Six potentially co-occurring evidence relations were mapped: exercise responsiveness, cardiometabolic association, source/secretion evidence, receptor/pathway evidence, functional perturbation, and formal mediation.&lt;/p&gt;Results&lt;p&gt;The searches yielded 3,388 records, of which 1,535 unique records underwent title/abstract screening and 397 reports underwent full-text assessment. The final primary evidence map comprised 365 reports representing 363 underlying studies, 413 exercise contrasts, 776 mediator-evidence observations, and 103 harmonized named mediators. Obesity/overweight was represented in 78.0% of studies. Among the 308 studies contributing named mediators, adipokines were represented in 58.4%, cytokines/chemokines in 32.1%, and myokines in 25.6%. Adiponectin, leptin, IL-6, and irisin were the most frequently represented named mediators. Exercise-responsive evidence and cardiometabolic associations were identified in 90.9% and 87.0% of contributing studies, respectively, whereas source/secretion evidence (18.5%), receptor/pathway evidence (9.7%), functional perturbation (11.4%), and formal mediation (0.3%) were less frequently represented. Chronic training accounted for 81.6% of exercise contrasts and aerobic/endurance exercise for 63.4%.&lt;/p&gt;Conclusions&lt;p&gt;Exercise-responsive mediator research in cardiometabolic disease comprises a concentrated group of recurrent adipokines, cytokines, and myokines alongside a broad, sparsely studied mediator landscape. Exercise-responsive evidence and cardiometabolic associations were frequently represented, whereas direct investigation of tissue source, downstream pathways, functional perturbation, and formal mediation was less common. Studies integrating well-characterized exercise exposures with serial mediator assessment, source validation, and mechanistic testing may help define how exercise-responsive signaling contributes to cardiometabolic adaptation.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-22T05:30:12Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fendo.2026.1892959.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Supplementary_file_2_Exercise-responsive_endocrine-metabolic_mediators_in_diabetes_and_cardiometabolic_disorders_a_systematic_scoping_review_and_evidence_map_xlsx/33961912</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
